Surgical eye robot performs precision-injection
Procedure shows that it is technically possible to safely dissolve a blood clot from the retinal vein with robotic support


Colin Kerr
Published: Thursday, January 26, 2017

A Phase 2 trial now has to show what the clinical effect is for patients with retinal vein occlusion"The operation was successful and is a first: the procedure shows that it is technically possible to safely dissolve a blood clot from the retinal vein with robotic support. A Phase 2 trial now has to show what the clinical effect is for patients with retinal vein occlusion," said a spokesman for the researchers
Latest Articles
Towards a Unified IOL Classification
The new IOL functional classification needs a strong and unified effort from surgeons, societies, and industry.
The 5 Ws of Post-Presbyopic IOL Enhancement
Fine-tuning refractive outcomes to meet patient expectations.
AI Shows Promise for Meibography Grading
Study demonstrates accuracy in detecting abnormalities and subtle changes in meibomian glands.
Are There Differences Between Male and Female Eyes?
TOGA Session panel underlined the need for more studies on gender differences.
Simulating Laser Vision Correction Outcomes
Individualised planning models could reduce ectasia risk and improve outcomes.
Need to Know: Aberrations, Aberrometry, and Aberropia
Understanding the nomenclature and techniques.
When Is It Time to Remove a Phakic IOL?
Close monitoring of endothelial cell loss in phakic IOL patients and timely explantation may avoid surgical complications.
Delivering Uncompromising Cataract Care
Expert panel considers tips and tricks for cataracts and compromised corneas.
Organising for Success
Professional and personal goals drive practice ownership and operational choices.